Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mandelli

Showing results (321-330 of 573) with videos related to

Pageof 58
Sort By:
Haematologica|September 1, 1995
Epidemiology of acute promyelocytic leukemiaA Mele, M A Stazi, A Pulsoni, et al.
Acta Haematologica|January 1, 1991
Thymopentin in the treatment of myelodysplastic syndromesR Latagliata, M C Petti, M A Aloe Spiriti, et al.
Early Human Development|June 1, 1992
Autoimmune thrombocytopenic purpura: maternal and fetal diseaseA Pachì, E Carapella, M G Mazzucconi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1985
Lymphocyte subpopulations and cell mediated cytotoxicity in acute non-lymphoid leukemia (ANLL) patients in complete remission (CR) and off-therapyG De Rossi, L Fontana, G de Sanctis, et al.
European Journal of Haematology|March 1, 1994
Classification of patients affected by multiple myeloma using a neural network softwareR Bugliosi, M Tribalto, G Avvisati, et al.
Blood|July 9, 1999
Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 casesF R Mauro, R Foa, D Giannarelli, et al.
Haematologica|June 1, 1979
Treatment of acute nonlymphocytic leukemia (ANLL) in elderly patients. Results of a multicentric studyF Mandelli, S Amadori, F Fabiani, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Ability of recombinant interferon gamma in vitro to restore the defective polymorphonuclear-cell- but not lymphocyte-mediated cytotoxic activities in patients with myelodysplastic syndromesG De Sanctis, V Bottari, A Frezzolini, et al.
Diagnostic Immunology|January 1, 1985
Impairment of cellular immunity and OKT4 lymphocytes in symptom-free hemophiliacs with antibodies to human T leukemia virus III (HTLV III)F Pandolfi, G De Rossi, G Mariani, et al.
European Journal of Haematology|September 1, 1990
Immunological definition of acute promyelocytic leukemia (FAB M3): a study of 39 casesG De Rossi, G Avvisati, S Coluzzi, et al.
Pageof 58

Showing results (321-330 of 573) with videos related to

Sort By:
Pageof 58
Haematologica|September 1, 1995
Epidemiology of acute promyelocytic leukemiaA Mele, M A Stazi, A Pulsoni, et al.
Acta Haematologica|January 1, 1991
Thymopentin in the treatment of myelodysplastic syndromesR Latagliata, M C Petti, M A Aloe Spiriti, et al.
Early Human Development|June 1, 1992
Autoimmune thrombocytopenic purpura: maternal and fetal diseaseA Pachì, E Carapella, M G Mazzucconi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1985
Lymphocyte subpopulations and cell mediated cytotoxicity in acute non-lymphoid leukemia (ANLL) patients in complete remission (CR) and off-therapyG De Rossi, L Fontana, G de Sanctis, et al.
European Journal of Haematology|March 1, 1994
Classification of patients affected by multiple myeloma using a neural network softwareR Bugliosi, M Tribalto, G Avvisati, et al.
Blood|July 9, 1999
Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 casesF R Mauro, R Foa, D Giannarelli, et al.
Haematologica|June 1, 1979
Treatment of acute nonlymphocytic leukemia (ANLL) in elderly patients. Results of a multicentric studyF Mandelli, S Amadori, F Fabiani, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Ability of recombinant interferon gamma in vitro to restore the defective polymorphonuclear-cell- but not lymphocyte-mediated cytotoxic activities in patients with myelodysplastic syndromesG De Sanctis, V Bottari, A Frezzolini, et al.
Diagnostic Immunology|January 1, 1985
Impairment of cellular immunity and OKT4 lymphocytes in symptom-free hemophiliacs with antibodies to human T leukemia virus III (HTLV III)F Pandolfi, G De Rossi, G Mariani, et al.
European Journal of Haematology|September 1, 1990
Immunological definition of acute promyelocytic leukemia (FAB M3): a study of 39 casesG De Rossi, G Avvisati, S Coluzzi, et al.
Pageof 58